SURTAVI
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
- Public sites
- 56
- Start date
- Apr 1, 2012
The Ohio State University Wexner Medical Center’s Structural Heart Disease Program evaluates and treats aortic and mitral valve disease with cardiologists, interventional cardiologists, cardiac surgeons and other specialists. Care includes valve repair and replacement, balloon valvuloplasty, minimally invasive procedures and transcatheter aortic valve replacement (TAVR) for aortic stenosis or regurgitation.
This description was generated by AI based on public sources. Data Sources and Methodology · Report inaccurate information
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mitral Valve Screening Survey
Columbus, OH
Columbus, OH
Columbus, OH